We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Consensus Estimate for revenues is pegged at $1.63 billion, indicating a rise of 17.6% from the prior-year quarter’s figure. The consensus mark for quarterly earnings has risen by a penny in the past 30 days to $1.36 per share. The consensus mark indicates a sharp increase from earnings of 49 cents per share reported in the prior-year quarter.
The consumer and professional product company has a trailing four-quarter earnings surprise of 122.9%, on average. CLX delivered an earnings surprise of 18.2% in the last reported quarter.
Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.
Factors Likely to Influence CLX’s Q1 Results
Clorox has been benefiting from pricing and cost-saving initiatives, which have been driving margins for a while now. Its efforts to expand the international foothold also bodes well. CLX has been on track with its IGNITE strategy, which aims at growth by focusing on innovation, digital commerce and brand building.
The company has been streamlining its operating model, which is likely to have improved efficiency and driven productivity. The streamlined operating model has been enhancing its ability to respond more quickly to changing consumer behaviors, innovate faster and increase cash flow driven by cost savings in the areas of selling and administration, supply chain, marketing and research and development. The aforesaid aspects are expected to have aided its quarterly performance. .
Our model predicts gross profit to increase 30.5% year over year and the gross margin to expand 420 basis points (bps) to 42.6%. We expect the operating margin to grow 20 bps.
However, Clorox has been witnessing higher advertising expenses for a while. We expect advertising costs to 1.3% year over year in the fiscal first quarter. In addition, any unfavorable price mix, lower volumes as well as the impact of the divestiture of the Argentina business and inflation act as concerns.
Our proven model predicts an earnings beat for Clorox this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.
Clorox currently has an Earnings ESP of +2.60% and a Zacks Rank of 2.
Other Stocks With the Favorable Combination
Here are other companies, which according to model, have the right combination of elements to beat on earnings this reporting cycle.
VITL is anticipated to register bottom and top-line growth when it reports third-quarter 2024 results. The Zacks Consensus Estimate for Vital Farms’ quarterly revenues is pegged at $142 million, indicating growth of 28.6% from the figure reported in the year-ago quarter.
The consensus estimate for Vital Farms’ earnings has been stable in the past 30 days at 14 cents per share. The consensus estimate indicates 40% growth from the year-ago quarter’s figure. VITL delivered an average earnings surprise of 82.5% in the trailing four quarters.
Mondelez International (MDLZ - Free Report) has an Earnings ESP of +0.82% and a Zacks Rank of 3 at present. MDLZ is likely to register bottom and top-line growth when it releases third-quarter results. The Zacks Consensus Estimate for its quarterly revenues is pegged at $9.1 billion, implying a rise of 0.5% from the year-ago quarter.
The consensus estimate for Mondelez’s quarterly earnings has remained unchanged in the past 30 days at 84 cents per share, indicating growth of 2.4% from the year-ago quarter’s number. MDLZ has a trailing four-quarter average earnings surprise of 7.8%.
Monster Beverage (MNST - Free Report) has an Earnings ESP of +0.45% and a Zacks Rank of 3 at present. MNST is likely to register bottom and top-line growth when it releases third-quarter results. The Zacks Consensus Estimate for its quarterly revenues is pegged at $1.92 billion, implying growth of 3.2% from the year-ago quarter.
The consensus estimate for Monster Beverage’s quarterly earnings has increased a penny in the past 30 days to 42 cents per share, indicating growth of 2.4% from the year-ago quarter’s number. MNST has a trailing four-quarter average negative earnings surprise of 3.4%.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Clorox Gears Up for Q1 Earnings: Here's What You Should Know
The Clorox Company (CLX - Free Report) is likely to register increases in the bottom and top lines when it reports first-quarter fiscal 2025 results on Oct. 30, 2024, after market close.
The Zacks Consensus Estimate for revenues is pegged at $1.63 billion, indicating a rise of 17.6% from the prior-year quarter’s figure. The consensus mark for quarterly earnings has risen by a penny in the past 30 days to $1.36 per share. The consensus mark indicates a sharp increase from earnings of 49 cents per share reported in the prior-year quarter.
The consumer and professional product company has a trailing four-quarter earnings surprise of 122.9%, on average. CLX delivered an earnings surprise of 18.2% in the last reported quarter.
Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.
Factors Likely to Influence CLX’s Q1 Results
Clorox has been benefiting from pricing and cost-saving initiatives, which have been driving margins for a while now. Its efforts to expand the international foothold also bodes well. CLX has been on track with its IGNITE strategy, which aims at growth by focusing on innovation, digital commerce and brand building.
The company has been streamlining its operating model, which is likely to have improved efficiency and driven productivity. The streamlined operating model has been enhancing its ability to respond more quickly to changing consumer behaviors, innovate faster and increase cash flow driven by cost savings in the areas of selling and administration, supply chain, marketing and research and development. The aforesaid aspects are expected to have aided its quarterly performance. .
Our model predicts gross profit to increase 30.5% year over year and the gross margin to expand 420 basis points (bps) to 42.6%. We expect the operating margin to grow 20 bps.
However, Clorox has been witnessing higher advertising expenses for a while. We expect advertising costs to 1.3% year over year in the fiscal first quarter. In addition, any unfavorable price mix, lower volumes as well as the impact of the divestiture of the Argentina business and inflation act as concerns.
The Clorox Company Price and EPS Surprise
The Clorox Company price-eps-surprise | The Clorox Company Quote
What the Zacks Model Unveils for CLX
Our proven model predicts an earnings beat for Clorox this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.
Clorox currently has an Earnings ESP of +2.60% and a Zacks Rank of 2.
Other Stocks With the Favorable Combination
Here are other companies, which according to model, have the right combination of elements to beat on earnings this reporting cycle.
Vital Farms (VITL - Free Report) currently has an Earnings ESP of +0.05% and a Zacks Rank of 2.You can see the complete list of today’s Zacks #1 Rank stocks here.
VITL is anticipated to register bottom and top-line growth when it reports third-quarter 2024 results. The Zacks Consensus Estimate for Vital Farms’ quarterly revenues is pegged at $142 million, indicating growth of 28.6% from the figure reported in the year-ago quarter.
The consensus estimate for Vital Farms’ earnings has been stable in the past 30 days at 14 cents per share. The consensus estimate indicates 40% growth from the year-ago quarter’s figure. VITL delivered an average earnings surprise of 82.5% in the trailing four quarters.
Mondelez International (MDLZ - Free Report) has an Earnings ESP of +0.82% and a Zacks Rank of 3 at present. MDLZ is likely to register bottom and top-line growth when it releases third-quarter results. The Zacks Consensus Estimate for its quarterly revenues is pegged at $9.1 billion, implying a rise of 0.5% from the year-ago quarter.
The consensus estimate for Mondelez’s quarterly earnings has remained unchanged in the past 30 days at 84 cents per share, indicating growth of 2.4% from the year-ago quarter’s number. MDLZ has a trailing four-quarter average earnings surprise of 7.8%.
Monster Beverage (MNST - Free Report) has an Earnings ESP of +0.45% and a Zacks Rank of 3 at present. MNST is likely to register bottom and top-line growth when it releases third-quarter results. The Zacks Consensus Estimate for its quarterly revenues is pegged at $1.92 billion, implying growth of 3.2% from the year-ago quarter.
The consensus estimate for Monster Beverage’s quarterly earnings has increased a penny in the past 30 days to 42 cents per share, indicating growth of 2.4% from the year-ago quarter’s number. MNST has a trailing four-quarter average negative earnings surprise of 3.4%.